Neuroma
17
3
3
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
12%
2 trials in Phase 3/4
25%
3 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (17)
Pain Outcomes After Digital Amputation Using Tulavi Allay™ Nerve Cap
High-Purity Type I Collagen Nerve Wrapping in Peripheral Nerve Procedures: A Prospective Registry
Neuroma-Associated Pain Management After Combat-Related Trauma in Ukraine
Targeted Muscle Reinnervation in the Hand for the Managment of Symptomatic Neuroma Following Digit and Hand Amputations
Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography
Regenerative Peripheral Nerve Interfaces to Treat Painful Digit and Hand Neuromas After Amputation
A Post Market Clinical Follow-up Study on Biomet Microfixation HTR PEKK (Midface), Facial & Mandibular Plates.
Postoperative Peripheral Nerve Stimulation for Management of Post-amputation Pain
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Neuromas as the Cause of Pain
Identification of Neuromas by High Resolution Ultrasound in Patients With Peripheral Nerve Injury and Amputations
Surgical Treatment of Symptomatic Neuroma "Stop Neuroma"
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Botulinum Toxin Type A for Neuroma Pain
Pathophysiology of Post Amputation Pain
ALGRX 4975 in the Treatment of Patients With Morton's Neuroma